WO2003009873A3 - Use of pulmonary surfactant as humectant - Google Patents

Use of pulmonary surfactant as humectant Download PDF

Info

Publication number
WO2003009873A3
WO2003009873A3 PCT/GB2002/003374 GB0203374W WO03009873A3 WO 2003009873 A3 WO2003009873 A3 WO 2003009873A3 GB 0203374 W GB0203374 W GB 0203374W WO 03009873 A3 WO03009873 A3 WO 03009873A3
Authority
WO
WIPO (PCT)
Prior art keywords
humectant
pulmonary surfactant
dry
sapl
irritant
Prior art date
Application number
PCT/GB2002/003374
Other languages
French (fr)
Other versions
WO2003009873A2 (en
Inventor
Derek Woodcock
John Staniforth
Joy Conway
Jim Thompson
Original Assignee
Britannia Pharmaceuticals Ltd
Derek Woodcock
John Staniforth
Joy Conway
Jim Thompson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Britannia Pharmaceuticals Ltd, Derek Woodcock, John Staniforth, Joy Conway, Jim Thompson filed Critical Britannia Pharmaceuticals Ltd
Priority to AU2002321402A priority Critical patent/AU2002321402A1/en
Publication of WO2003009873A2 publication Critical patent/WO2003009873A2/en
Publication of WO2003009873A3 publication Critical patent/WO2003009873A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus

Abstract

A surface active phospholipid (SAPL) composition, especially a dry powder blend of dipalmitoyl phosphatidyl choline and phosphatidyl glycerol, is used as a non-therapeutic pulmonary humectant or anti-irritant by inhalation into the airways and upper respiratory tract of a person experiencing dry or dusty atmospheres.
PCT/GB2002/003374 2001-07-23 2002-07-23 Use of pulmonary surfactant as humectant WO2003009873A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002321402A AU2002321402A1 (en) 2001-07-23 2002-07-23 Use of pulmonary surfactant as humectant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0117911.8A GB0117911D0 (en) 2001-07-23 2001-07-23 Pulmonary humectant
GB0117911.8 2001-07-23

Publications (2)

Publication Number Publication Date
WO2003009873A2 WO2003009873A2 (en) 2003-02-06
WO2003009873A3 true WO2003009873A3 (en) 2003-11-20

Family

ID=9919011

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/003374 WO2003009873A2 (en) 2001-07-23 2002-07-23 Use of pulmonary surfactant as humectant

Country Status (3)

Country Link
AU (1) AU2002321402A1 (en)
GB (1) GB0117911D0 (en)
WO (1) WO2003009873A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146570A1 (en) * 1980-12-06 1982-07-08 Dr.med. Dietrich Ibiza Reichert Composition for controlling snoring
US5663198A (en) * 1993-07-15 1997-09-02 Hoechst Aktiengesellschaft Drug formulations comprising coated, very sparingly water-soluble drugs for inhalational pharmaceutical forms, and process for their preparation
WO1999027920A2 (en) * 1997-12-03 1999-06-10 Britannia Pharmaceuticals Limited Use of phospholipids for the manufacture of a medicament for the treatment of asthma
WO2001058423A1 (en) * 2000-02-11 2001-08-16 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3146570A1 (en) * 1980-12-06 1982-07-08 Dr.med. Dietrich Ibiza Reichert Composition for controlling snoring
US5663198A (en) * 1993-07-15 1997-09-02 Hoechst Aktiengesellschaft Drug formulations comprising coated, very sparingly water-soluble drugs for inhalational pharmaceutical forms, and process for their preparation
WO1999027920A2 (en) * 1997-12-03 1999-06-10 Britannia Pharmaceuticals Limited Use of phospholipids for the manufacture of a medicament for the treatment of asthma
EP1082108A2 (en) * 1997-12-03 2001-03-14 Britannia Pharmaceuticals Limited Improvements in medicaments for asthma treatment
WO2001058423A1 (en) * 2000-02-11 2001-08-16 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GRIESE M: "PULMONARY SURFACTANT IN HEALTH AND HUMAN LUNG DISEASES: STATE OF THE ART", EUROPEAN RESPIRATORY JOURNAL, MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK, vol. 13, no. 6, June 1999 (1999-06-01), pages 1455 - 1476, XP000971645, ISSN: 0903-1936 *
MORLEY C J ET AL: "DRY PULMONARY SURFACTANT ITS PHYSICAL AND PHYSIOLOGICAL PROPERTIES", PEDIATRIC RESEARCH, vol. 11, no. 9 PART 2, 1977, pages 1026, XP009005717, ISSN: 0031-3998 *
MORLEY C J: "Prophylactic treatment of premature babies with artificial surfactant (ALEC).", DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS. SWITZERLAND 1989, vol. 13, no. 2-4, 1989, pages 182 - 183, XP001062114, ISSN: 0379-8305 *

Also Published As

Publication number Publication date
GB0117911D0 (en) 2001-09-12
WO2003009873A2 (en) 2003-02-06
AU2002321402A1 (en) 2003-02-17

Similar Documents

Publication Publication Date Title
BR9913722A (en) Particles for delivering an active agent to the alveoli of a human patient, and method for preparing them, method for delivering an active agent to the lungs of a human patient, and method for increasing the amount of an inhaled active agent deposited in the lung. deep
CY1115304T1 (en) PHARMACEUTICAL COMPOSITIONS FOR INHALATION
DE59914603D1 (en) Multidose dry powder inhaler with powder reservoir
TR200002692T2 (en) Administration of the aerosolized active substance.
WO1999027920A3 (en) Use of phospholipids for the manufacture of a medicament for the treatment of asthma
ES2178943A1 (en) Aerosol composition comprising formoterol
MY114665A (en) Use of mometasone furoate for treating airway passage and lung diseases
DE60025019D1 (en) DRY POWDER COMPOSITIONS WITH IMPROVED DISPERSITY
SI2042168T1 (en) Inhalation formulation comprising phenethanolamine derivatives for the treatment of respiratory diseases
CA2412561A1 (en) Highly efficient delivery of a large therapeutic mass aerosol
CA2183577A1 (en) Methods and compositions for pulmonary delivery of insulin
CA2334411A1 (en) Use of a composition comprising formoterol and budesonide for the prevention or treatment of an acute condition of asthma
WO2002032410A3 (en) Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders
ES2162865T3 (en) COMPOSITIONS FOR INHALATION.
SE8603812D0 (en) ADMINISTRATION OF LIPOSOMES TO MAMMALS
DK1019033T3 (en) New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g / ml which includes budesonide
WO2005063777A8 (en) Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
NO993538L (en) New formulation for inhalation having a bulk density at a slope of 0.28 to 0.38 g / ml, comprising formoterol
NO20051463L (en) Inhalation compositions with high drug content
WO2003009873A3 (en) Use of pulmonary surfactant as humectant
WO2005025498A3 (en) Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
WO2004091487A3 (en) Hemophilia treatment by inhalation of coagulation factors
WO2005041922A3 (en) Composition
NO993540D0 (en) New formulation for inhalation having bulk density at a slope of 0.28 to 0.38 g / ml, comprising the formulation and use thereof
ATE520405T1 (en) INHALATION COMPOSITION

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP